logo
Book a meeting
TargetCancer Foundation

Target Cancer Foundation

Research, 955 Ave, Cambridge, Massachusetts, 02139, United States, 1-10 Employees

targetcancerfoundation.org

  • facebook
  • twitter
  • LinkedIn

Who is TARGETCANCER FOUNDATION

TargetCancer Foundation promotes the development of lifesaving treatment protocols for rare cancers. TargetCancer Foundation directly supports initiatives at the forefront of cancer treat...

Read More

lock icon Get Full Access
map
  • 955 Massachusetts Ave, Cambridge, Massachusetts, 02139, United States Headquarters: 955 Massachusetts Ave, Cambridge, Massachusetts, 02139, United States
  • 2009 Date Founded: 2009
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Research

SIC SIC Code: 6531

checked-icon Does something look wrong? Fix it. | View contact records from TARGETCANCER FOUNDATION

TargetCancer Foundation Org Chart and Mapping

Employees
Kristen Palma

Kristen Palma

President

Jim Palma

Jim Palma

Executive Director

See Full Org Chart arrow
email-formate-icon
View Email Formats for TargetCancer Foundation
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding TargetCancer Foundation

Answer: TargetCancer Foundation's headquarters are located at 955 Ave, Cambridge, Massachusetts, 02139, United States

Answer: TargetCancer Foundation's official website is https://targetcancerfoundation.org

Answer: TargetCancer Foundation's revenue is $1 Million to $5 Million

Answer: TargetCancer Foundation's SIC: 6531

Answer: TargetCancer Foundation has 1-10 employees

Answer: TargetCancer Foundation is in Research

Answer: TargetCancer Foundation contact info: Phone number: Website: https://targetcancerfoundation.org

Answer: TargetCancer Foundation promotes the development of lifesaving treatment protocols for rare cancers. TargetCancer Foundation directly supports initiatives at the forefront of cancer treatment by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients. TargetCancer Foundation was founded by Paul Poth in 2009 after his diagnosis with cholangiocarcinoma at age 38. Because his cancer was rare, no treatments existed for it, and very little research was being carried out. Paul passed away in August 2009, but TargetCancer Foundation continues his effort to ensure that others diagnosed with rare cancers will have real treatment options and a chance to live. By granting seed money to critical research projects that would not otherwise be supported at their initial stages, TargetCancer Foundation supports young, courageous scientists who are committed to finding effective new therapies for rare cancers, and ultimately, all cancers. Since being founded, TargetCancer Foundation has provided over $250,000 in grant funding supporting innovative, high impact research into cholangiocarcinoma and esophageal cancer. In addition, TargetCancer Foundation has funded a fellowship supporting the studies of Harvard Medical School students, and also supported next generation research at the Center for Molecular Therapeutics at Massachusetts General Hospital.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access